SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-21-000125
Filing Date
2021-11-08
Accepted
2021-11-08 16:15:28
Documents
15
Period of Report
2021-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20211105.htm   iXBRL 8-K 41647
2 EX-99.1 q32021financialresultsrele.htm EX-99.1 110924
6 GRAPHIC tcda-20211105_g1.jpg GRAPHIC 5018
7 GRAPHIC tricidalogoa03a.jpg GRAPHIC 6561
  Complete submission text file 0001595585-21-000125.txt   328964

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20211105.xsd EX-101.SCH 1912
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20211105_lab.xml EX-101.LAB 25149
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20211105_pre.xml EX-101.PRE 13056
8 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20211105_htm.xml XML 11377
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 211388137
SIC: 2834 Pharmaceutical Preparations